• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

DNA-repair gene polymorphisms predict clinical outcome among patients with head and neck cancer

Research Project

Project/Area Number 17K11391
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Otorhinolaryngology
Research InstitutionUniversity of the Ryukyus

Principal Investigator

Hirakawa Hitoshi  琉球大学, 医学部附属病院, 講師 (50437993)

Co-Investigator(Kenkyū-buntansha) 池上 太郎  琉球大学, 医学(系)研究科(研究院), 助教 (00754409)
山下 懐  琉球大学, 医学(系)研究科(研究院), 助教 (60569622)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsDNA修復酵素遺伝子多型 / 頭頸部癌 / 手術 / 化学放射線療法 / 遺伝子多型 / DNA修復酵素 / DNA修復酵素の遺伝子多型 / ERCC1 / XRCC1 / 化学療法 / 放射線療法
Outline of Final Research Achievements

Purpose: To evaluate the prognostic significance of DNA excision repair gene polymorphisms, excision repair cross-complementation group 1 (ERCC1) and X-ray repair complementing defective repair in Chinese hamster cells 1 (XRCC1) polymorphisms were investigated in Japanese patients with head and neck squamous cell carcinoma (HNSCC). Methods: A total of 225 consecutive patients with HNSCC who underwent surgery or chemoradiotherapy/radiotherapy (CRT/RT) were recruited.
Results: Multivariate analysis showed that carriers with the ERCC1 8092 (C/A+A/A) genotype (hazard ratio, 3.56; 95% confidence interval, 1.22-7.39; p = 0.02) had significantly worse survival than those with ERCC1 8092 C/C who received CRT/RT. Conversely, the XRCC1 Arg399Gln polymorphism did not influence survival in patients who received CRT/RT as well as surgery.
The ERCC1 C8092A polymorphism might be an independent predictor of response to CRT and survival outcome in patients with HNSCC.

Academic Significance and Societal Importance of the Research Achievements

DNA修復酵素遺伝子多型(ERCC1、XRCC1)は地域差、民族差があり、他民族や、他国のそれを参考にすることができない。われわれは沖縄県におけるDAN修復酵素遺伝子多型を調べることにより、頭頸部癌多発地域である本県において独自の研究を行った。侵襲の少ない末梢血からの採血でDNA修復酵素遺伝子多型を検討することにより頭頸部癌の治療選択(手術か化学放射線治療か)ができる可能性を見出した。
今後さらに症例を集積し同研究を発展させていく必要があると考えた。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (3 results)

All 2019 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results)

  • [Journal Article] Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma.2017

    • Author(s)
      Hirakawa H, Hanai N, Suzuki H, Nishikawa D, Matayoshi S, Hasegawa Y
    • Journal Title

      Jpn J Clin Oncol.

      Volume: 47 Issue: 11 Pages: 1038-1046

    • DOI

      10.1093/jjco/hyx097

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] DNA修復酵素遺伝子多型解析による頭頸部癌治療の効果予測2019

    • Author(s)
      平川仁
    • Organizer
      第120回日本耳鼻咽喉科学会・学術総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] DNA修復酵素遺伝子多型解析による頭頸部癌治療の効果予測2017

    • Author(s)
      平川仁
    • Organizer
      日本耳鼻咽喉科学会総会
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi